Find all of our publications, videos, reports and more.
The evaluation was extremely positive and strongly supported Australia’s reputation as a world leader in implementing school-based immunisation programs and preventing HPV-related cancers and disease.
The Australian Medical Research Advisory Board used this presentation during public consultations when they were developing the MRFF Priorities for 2018–20.
The National Immunisation Program (NIP) vaccine listing process sets out the regulatory steps that must occur in order for a vaccine to be supplied through the NIP.
The Australian Medical Research Advisory Board used this discussion paper as part of its consultation process when developing the 2018–20 MRFF priorities.
The influenza vaccine is provided at no cost for pregnant women through the National Immunisation Program. If you’re pregnant, speak to your doctor, nurse, or midwife today.
A summary of the major items discussed at the fourth MDAF meeting.Part of a collection:
This summary of the Medical Technology, Biotechnology and Pharmaceutical (MTP) Sector growth plan includes a profile of the current sector, the growth plan and the future outlook.